Zhejiang Hengkang Pharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files and 9 valid CEPs across a filed portfolio of 8 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sanmen, China | Not on file |
| China, China | 3022190702 |
| Molecule | Regulators | Docs |
|---|---|---|
| Mesalazine | EDQM, US FDA | 3 |
| Deferasirox | EDQM, US FDA | 2 |
| Tenoxicam | EDQM | 2 |
| Acemetacin | EDQM | 1 |
| Amiodarone Hydrochloride | EDQM | 1 |
| Benserazide | EDQM | 1 |
| Benserazide Hydrochloride | EDQM | 1 |
| Eltrombopag | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 2 |
| US FDA | None | 1 |
Choose your molecules and target markets. Zhejiang Hengkang Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free